Cargando…

Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer

Background: Tumor microenvironment (TME) has been reported to have a strong association with tumor progression and therapeutic outcome, and epigenetic modifications such as DNA methylation can affect TMB and play an indispensable role in tumorigenesis. However, the potential mechanisms of TME and DN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bangquan, Zhai, Jiabao, Wang, Wanyu, Liu, Tianyu, Liu, Chang, Zhu, Xiaojie, Wang, Qi, Tian, Wenjing, Zhang, Fubin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061945/ https://www.ncbi.nlm.nih.gov/pubmed/35517856 http://dx.doi.org/10.3389/fmolb.2022.872932

Ejemplares similares

Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer
por: Han, Xu, et al.
Publicado: (2022)

The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma
por: Gao, Jun, et al.
Publicado: (2023)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
por: Ji, Fei, et al.
Publicado: (2021)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma
por: Li, Rui, et al.
Publicado: (2022)

Identification of Clinical and Tumor Microenvironment Characteristics of Hypoxia-Related Risk Signature in Lung Adenocarcinoma
por: Dai, Zili, et al.
Publicado: (2021)

Extracellular Matrix-Based Gene Expression Signature Defines Two Prognostic Subtypes of Hepatocellular Carcinoma With Different Immune Microenvironment Characteristics
por: Tang, Hui, et al.
Publicado: (2022)

A Glycolysis-Related Gene Signature Correlates With the Characteristics of the Tumor Immune Microenvironment and Predicts Prognosis in Patients With Hepatocellular Carcinoma
por: Yang, Jun, et al.
Publicado: (2022)

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma
por: Zuo, Zhihua, et al.
Publicado: (2021)

Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures
por: Zhang, Congjun, et al.
Publicado: (2021)

Aberrant Methylation and Immune Microenvironment Are Associated With Overexpressed Fibronectin 1: A Diagnostic and Prognostic Target in Head and Neck Squamous Cell Carcinoma
por: Sheng, Surui, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer
por: Jiang, Minxiao, et al.
Publicado: (2021)

An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma
por: Hong, Xiaoling, et al.
Publicado: (2023)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma
por: Liu, Lixia, et al.
Publicado: (2021)

Editorial: Tumor microenvironment in cancer hallmarks and therapeutics
por: Luo, Na
Publicado: (2022)

CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change
por: Tian, Wei-Jie, et al.
Publicado: (2021)

Development and Verification of a Hypoxic Gene Signature for Predicting Prognosis, Immune Microenvironment, and Chemosensitivity for Osteosarcoma
por: Wu, Fengfeng, et al.
Publicado: (2022)

Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma
por: Zhang, Bixi, et al.
Publicado: (2022)

Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer
por: Li, Luyi, et al.
Publicado: (2021)

An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer
por: Xie, Fengxiao, et al.
Publicado: (2022)

Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis
por: Liu, Yi, et al.
Publicado: (2021)

CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis
por: Guo, Lihao, et al.
Publicado: (2021)

Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis
por: Dasari, Subramanyam, et al.
Publicado: (2023)

Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics
por: Shi, Rongchen, et al.
Publicado: (2023)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

A Novel Prognostic Model of Endometrial Carcinoma Based on Clinical Variables and Oncogenomic Gene Signature
por: Deng, Fang, et al.
Publicado: (2021)

Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma
por: Feng, Xiaofei, et al.
Publicado: (2021)

TRPV4 is a Prognostic Biomarker that Correlates with the Immunosuppressive Microenvironment and Chemoresistance of Anti-Cancer Drugs
por: Wang, Kai, et al.
Publicado: (2021)

Prognostic value, immune signature and molecular mechanisms of the SUMO family in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma
por: Li, Xiaomeng, et al.
Publicado: (2021)

Development and Validation of a Prognostic Gene Signature in Clear Cell Renal Cell Carcinoma
por: Zhan, Chuanchuan, et al.
Publicado: (2021)

Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer
por: Dai, Wentao, et al.
Publicado: (2020)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer
por: Zheng, Hang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f836gn5ana225tor4jrsbo85l5